March 18, 2025
Summary: Ukrainian mobile app developer Boosters has sold its popular sleep improvement app, Avrora, to American entrepreneur Ken Colbert. Colbert, who recently founded his own app development company, One Eleven, sees significant potential in Avrora and plans to further develop and expand its user base. Boosters’ CEO, Mykhailo Galian, decided to sell the app to…
Read More
Summary: Research from the Indiana University Kelley School of Business has found that workplace mistreatment disproportionately impacts Black employees, leading to significantly higher rates of sleep loss and depression compared to white employees. The study suggests that Black employees are more likely to attribute mistreatment to racial prejudice, which exacerbates the negative effects on their…
Read More
Summary: Congressman Tony Cárdenas, Congresswoman Kim Schrier, and Senator Richard Blumenthal have introduced the Safeguarding Infants from Dangerous Sleep Act, a bill aimed at banning weighted sleep products such as swaddles, sleep sacks, and blankets that pose significant risks to infants by restricting their movement and potentially impeding their breathing during unsupervised sleep. This legislation…
Read More
Summary: ProSomnus Sleep Technologies, a maker of oral appliance therapy for obstructive sleep apnea (OSA), reported record revenues of $9.1 million for Q2 2024, marking a 31% increase over the same period last year and a 22% increase from Q1 2024. The company emerged from Chapter 11 bankruptcy on Aug 5, with a reorganized structure…
Read More
Summary: The US Food and Drug Administration (FDA) has cleared SleepioRx, a digital therapeutic developed by Big Health for the treatment of chronic insomnia. SleepioRx employs cognitive behavioral therapy for insomnia (CBT-I) to address the cognitive and behavioral factors that sustain insomnia. The therapeutic has demonstrated efficacy in clinical trials, showing up to 76% of…
Read More
Summary: A study by the National University of Singapore (NUS) found that supplementation with 5-Hydroxytryptophan (5-HTP) significantly improves sleep quality and gut microbiota composition in older adults, particularly those with poor sleep patterns. The 12-week clinical trial revealed that 5-HTP enhances sleep by modulating neurotransmitters involved in the sleep-wake cycle and boosts gut health, indicating…
Read More
Summary: A recent survey has found that Samsung’s WindFree air conditioner is primarily chosen for its ability to enhance sleep quality, with 58% of users citing “comfortable sleep” as their main reason. The technology, which evenly distributes airflow through micro air holes, has seen global sales growth since its launch in 2017, according to Samsung.…
Read More
Summary: Avadel Pharmaceuticals announced its second-quarter results, highlighting the progress of its narcolepsy drug, Lumryz. The company initiated a phase 3 trial for Lumryz in idiopathic hypersomnia and awaits an FDA decision on its use in pediatric narcolepsy. Lumryz, approved by the FDA as a once-at-bedtime treatment for cataplexy or excessive daytime sleepiness in adults,…
Read More
Summary: The Board of Registered Polysomnographic Technologists (BRPT) announced Griselda Molina from Westminster, Colo, as the winner of its A-STEP/STAR Educational Grant Program. Chosen from over 40 applications across 23 states and several countries, Molina, with a decade of experience in sleep technology, demonstrated a commitment to advancing her knowledge and skills. The grant provides…
Read More
Summary: A new study reveals a link between loneliness and more frequent, intense nightmares. The research suggests that stress, rumination, and hyperarousal, common in lonely individuals, contribute to these nightmares. The findings align with the evolutionary theory that human connection is crucial for survival and well-being. Key Takeaways: Link Between Loneliness and Nightmares: Lonely individuals…
Read More